Priority Date: 21.04.11 (US 201161477794P)

PROTEIN FOR USE AS A MEDICAMENT

  • Application ID: EP12715401
  • Status: EXAMINATION IN PROGRESS

Applicant

Attorneys

no operation time available
2 offices
Technology Company
no operation time available
7 offices
Technology Company

Specialization

This EP application has the IPC class A61, C07, and C12. Merck Sharp & Dohme Ltd. and Intervet International BV are specialized in the combination A61, C07, and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 133 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 21.04.2011 - Priority Date (US 201161477794P)
  • 26.10.2012 - Publication A1 (WO2012143488)
  • 26.02.2014 - Publication A1 (EP2699677)